ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 636009 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 636009; 2) Community: the network communities that were significantly associated with the response to NSC 636009; 3) Molecule: the relationships between components within communities and NSC 636009; 4) MDR: the compounds that were significantly associated with the NSC 636009.

NSC Compound Enrichment Correlation
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0115521552688258 0.15087438
NSC 116878 Cardiac glycoside 0.0123744972338278 0.089379237
NSC 245398 Null 0.0123744972338278 0.12880346
NSC 250682 Oridonin 0.0123744972338278 0.25443164
NSC 340847 4-Selenazolecarboxamide, 2-.beta.-D-ribofuranosyl- 0.0123744972338278 -0.12618144
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 0.0123744972338278 -0.14740721
NSC 627748 Null 0.0123744972338278 -0.011387664
NSC 627986 Null 0.0123744972338278 0.34314577
NSC 628141 Null 0.0123744972338278 -0.01598976
NSC 643419 Null 0.0123744972338279 0.19750867
Total:57  Current:13    [First] [Prev] [Next] [Last]